Pacific Biosciences of California, Inc. (PACB)

PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	11.7	12.06	12.75	11.78	11.17
Revenue Growth (YoY)	-2.99%	-5.43%	8.23%	5.53%	20.09%
Cost of Revenue	8.99	9.51	9.45	12.16	6.71
Gross Profit	2.7	2.55	3.3	-0.38	4.46
Selling, General & Admin	21.33	31.23	39.19	49.24	46.9
Research & Development	16.69	25.35	26.92	21.94	21.26
Total Operating Expenses	38.01	56.58	66.11	71.18	68.16
Operating Income	-35.31	-54.03	-62.81	-71.56	-63.7
Interest Income	0.7	1.12	0.55	0.09	0.86
Interest Expense	-13.12	-7.74	-3.77	-15.55	-15.55
Other Non-Operating Income (Expense)	-2.39	-0.12	3.46	9.36	0.19
Total Non-Operating Income (Expense)	-14.8	-6.74	0.24	-6.1	-14.5
Pretax Income	-50.11	-60.77	-62.57	-77.66	-78.2
Provision for Income Taxes	-0.07	0.85	-0.08	0.05	0.01
Net Income	-50.05	-61.62	-62.49	-77.7	-78.21
Net Income to Common	-50.05	-61.62	-62.49	-77.7	-78.21
Shares Outstanding (Basic)	274	254	225	204	165
Shares Outstanding (Diluted)	288	254	225	204	175
Shares Change (YoY)	13.70%	12.95%	10.00%	16.67%	14.71%
EPS (Basic)	-1.13	-1.21	-1.40	-0.89	0.18
EPS (Diluted)	-1.59	-1.21	-1.40	-0.89	0.17
Free Cash Flow	-24.7	-41.23	-49.28	-47.93	-51.76
Free Cash Flow Per Share	-0.09	-0.16	-0.22	-0.23	-0.30
Gross Margin	23.12%	21.15%	25.90%	-3.23%	39.94%
Operating Margin	-301.85%	-448.03%	-492.51%	-607.37%	-570.53%
Profit Margin	-427.81%	-510.97%	-490.06%	-659.50%	-700.47%
FCF Margin	-211.17%	-341.91%	-386.46%	-406.77%	-463.56%
EBITDA	-31.89	-50.77	-59.81	-69.04	-60.7
EBITDA Margin	-272.60%	-421.05%	-468.99%	-586.00%	-543.69%
EBIT	-35.31	-54.03	-62.81	-71.56	-63.7
EBIT Margin	-301.85%	-448.03%	-492.51%	-607.37%	-570.53%
Effective Tax Rate	0.13%	-1.40%	0.12%	-0.06%	-0.01%

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q